Breast Cancer Diagnostics Market To Witness Substantial Growth In The Forecast Period 2022-2031 | Abbott Laboratories, Myriad Genetics Inc, Hologic Inc

The global breast cancer diagnostics market size is expected to grow from $3.75 billion in 2021 to $4.06 billion in 2022 at a compound annual growth rate (CAGR) of 8.3%. The global breast cancer diagnostic market is then expected to grow to $5.48 billion in 2026 at a CAGR of 7.8%.

The Business Research Company offers the Breast Cancer Diagnostics Global Market Report 2022 in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market's historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.

Request FREE SAMPLE COPY of this research study:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3284&type=smp

The breast cancer diagnostics market consists of sales of breast cancer diagnostic devices and related services by entities (organizations, sole traders, and partnerships) that produce breast cancer diagnostics devices. These devices are used to diagnose breast cancer. Only goods and services traded between entities or sold to end consumers are included.

Some key breast cancer diagnostics market players are Abbott Laboratories, Myriad Genetics Inc, Hologic Inc, Koninklijke Philips N.V, Fujifilm Holdings Corporation, GE Healthcare, Thermo Fischer Scientific Inc, Siemens AG, NanoString Technologies Inc, and C. R. Bard Inc.

The countries covered in the global breast cancer diagnostics market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global breast cancer diagnostics market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Breast Cancer Diagnostics Market Segmentation:

By Type
1. Imaging
2. Biopsy
3. Genomic Tests
4. Blood Tests

By Technology
1. Fluorescent In Situ Hybridization (FISH)
2. Comparative Genomic Hybridization (CGH)
3. Immunohistochemical (IHC)

By Cancer Type
1. BRCA Breast Cancer
2. ER and PR Breast Cancer
3. HER 2 Breast Cancer
4. EGFR Mutation Test Breast Cancer

By Diagnostic Type
1. Ionizing Breast Imaging Technologies
2. Non-Ionizing Imaging Technologies

By End-User
1. Hospitals and Clinics
2. Cancer Research Centers
3. Diagnostic Laboratories
4. Ambulatory Surgical Centers

See more on the report at https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report

The Report's Table Of Contents includes
1. Executive Summary
2. Breast Cancer Diagnostics Market Characteristics
3. Breast Cancer Diagnostics Market Trends And Strategies
4. Impact Of COVID-19 On Breast Cancer Diagnostics
5. Breast Cancer Diagnostics Market Size And Growth
……
26. Africa Breast Cancer Diagnostics Market
27. Breast Cancer Diagnostics Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Breast Cancer Diagnostics Market
29. Breast Cancer Diagnostics Market Future Outlook and Potential Analysis
30. Appendix

This report covers the trends and market dynamics of the breast cancer diagnostics market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Directly purchase the report here: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3284

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our blog: http://blog.tbrc.info/
And follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

About Us:
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. It has published over 3000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

This release was published on openPR.